PrognostiCheck® Value Proposition Strategy and Focus.
•
1 like•244 views
The document describes a prognostic assessment tool called Prognosticheck that provides reliable health information to help guide medical decisions. It targets its individually tailored curriculum to patients, physicians, facilities, manufacturers, and others. It addresses the chronic disease model, changes in healthcare delivery systems, and evolving ethical and cultural expectations around decision making at the end of life. Prognosticheck aims to characterize disease severity and progression, evaluate treatment effectiveness, and time an individual's non-acute death to better inform palliative care and hospice.
Recommended
More Related Content
Similar to PrognostiCheck® Value Proposition Strategy and Focus.
Similar to PrognostiCheck® Value Proposition Strategy and Focus. (20)
More from IPGDx LLC
More from IPGDx LLC (13)
Recently uploaded
Recently uploaded (20)
PrognostiCheck® Value Proposition Strategy and Focus.
- 2. PROGNOSTICHECK® Value Proposition: Strategy & Focus
- 3. STRATEGY & FOCUS Reliable information to base healthcare decisions upon Scientific Excellent Compassionate knowledge training & caring base support communication Structured Specific to: Pre-Learning multi-media formats Patient, Physician, Assessment Manufacturer ©2005 IPGDx, LLC
- 4. INDIVIDUALLY TARGETED CURRICULUM • Patient’s and Families • Physicians – Other healthcare providers • Nurses • Facilities – Phase of care • Manufacturers – Pharmaceuticals/Other Interventions • Prescription • Nonprescription ©2005 IPGDx, LLC
- 5. THREE FRONTS OF CHANGE • Chronic disease model – Therapeutic efficacy • Healthcare delivery system – Changing roles • Ethical and cultural expectations – Duties and responsibilities within a new decision paradigm ©2005 IPGDx, LLC
- 6. CHRONIC DISEASE • Diagnosis established • Tx limited/repetitive • Course is long/progressive • Complications – Anticipation – Avoidance – Mitigation • Speed of progression • Scope of deterioration ©2005 IPGDx, LLC
- 7. CHARACTER OF CHRONIC ILLNESS • Nonfatal (Complication Avoidance) – Occurs with substantial reserve capacity – Progressively long natural course • Serious then fatal – Progressively worsening – Serial exacerbations to death • Frailty/prolonged dwindling (Cliff Edge) – Little available reserves – Small upset cascades ©2005 IPGDx, LLC
- 8. Hospitalizations • Severity of disease – Present on admission – Nosocomial or not • Overstaying DRG LOS – Complications • ICU Resource allocation – SIRS ©2005 IPGDx, LLC
- 9. From: ‘Living Well at the End of Life’; Lynn & Adamson 2003 Rand Health ©2005 IPGDx, LLC
- 10. ~20% ~20% ~40% ©2005 IPGDx, LLC *~20% other and/or undefined
- 11. ©2005 IPGDx, LLC
- 12. Of the ~2.5M annual deaths less than forty percent died under hospice care ©2005 IPGDx, LLC
- 13. THOSE WITH CHRONIC DISEASE ©2005 IPGDx, LLC
- 14. CHANGES IN HEALTHCARE DELIVERY • Physician – < economic independence – < professional autonomy – > external review – > administrative oversight • Called upon to: – Optimize outcome while minimizing costs – Proffer decisions with weighted administrative and clinical consequences ©2005 IPGDx, LLC
- 15. CHANGES IN HEALTHCARE DELIVERY • Resource Allocation – > need – > cost – To produce > benefit – Comparative metric/risk adjustments – Relative levels of illness and treatment • System comparisons ©2005 IPGDx, LLC
- 16. CHANGES IN HEALTHCARE DELIVERY • Demonstrated Effectiveness – Assessment of the probability of expected course and outcomes • Assumption of therapeutic efficacy – Intermediate endpoints predictive of long-term outcomes • Predictive findings • Pre-symptomatic – occult illness • Predicting consequences – Benefit of advanced interventions – Adherence metrics ©2005 IPGDx, LLC
- 17. ©2005 IPGDx, LLC
- 18. ETHICAL DECISION MAKING • Communication required • Consumerism • Informed consent • Risk (cost) / Benefit • Resources – Availability – Allocation ©2005 IPGDx, LLC
- 19. ©2005 IPGDx, LLC
- 20. END OF LIFE COSTS ©2005 IPGDx, LLC
- 21. CULTURAL EXPECTATIONS • Futility of intervention (flogging) • Outcome inevitability – Likelihood of recovery – Effectiveness v trauma of intervention • Justice • Beneficence • Economy ©2005 IPGDx, LLC
- 22. END OF LIFE CARE • > Consciousness of EOL care and death • ‘Good Death’ v “BAD” – Control-Comfort-Communication – Discussed with family – Planned for – Meaningful assessments – Management of – Home care • Physical-Spiritual-Emotional-Social-Cost ©2005 IPGDx, LLC
- 23. ©2005 IPGDx, LLC
- 24. ©2005 IPGDx, LLC
- 25. ©2005 IPGDx, LLC
- 26. ©2005 IPGDx, LLC
- 27. ©2005 IPGDx, LLC
- 28. PROGNOSTICHECK® • If Sick, How Sick® • Prognosis – Characterization of disease • Presence-Severity-Progression – Effectiveness of therapies • Optimized individual response – Timing of non-acute death • Palliative care and Hospice ©2005 IPGDx, LLC
- 29. TARGETED MARKET SEGMENTS Innovators First 5% - 10% that adopt the product Early Adopters Next 10% - 15% Early MajorityNext 30% Late Majority Next 30% Laggards Remaining 20% CHARACTERISTICS: Venturesomeness: the willingness and desire to be daring in trying something new and different Social integration: frequent and extensive contact with others in one’s area Cosmopolitan: point of view extending beyond the immediate neighborhood or community Social mobility: upward movement on the social scale Privilegedness: attitude and possession of money (less risky to try something new) ©2005 IPGDx, LLC
- 30. ©2005 IPGDx, LLC
- 31. ©2005 IPGDx, LLC